See his collected poems (1908); his autobiography, To Return to All That (1930). Robert Graves is his son.
See M. Graves; Buildings and Projects 1966-81 (1983) and Buildings and Projects 1982-89 (1990).
See his Collected Poems (1965), Collected Short Stories (1965), Poems, 1968-1970 (1970), and Poems 1970-1972 (1973), and a collection of essays, Difficult Questions, Easy Answers (1974). See also biographies by M. S. Smith (1983), R. P. Graves (1987), and M. Seymour (1995); studies by M. Kirkham (1969) and P. J. Keane (1980); bibliography by W. P. Williams and F. H. Higginson (2d ed. 1987).
(born Feb. 25, 1752, Cotterstock, Northamptonshire, Eng.—died Oct. 26, 1806, Exeter, Devonshire) British soldier and colonial administrator in Canada. He served in the American Revolution as commander of the Queen's Rangers (1777–79). He was taken prisoner (1779) but later released (1781) and invalided back to England. After the Constitutional Act was passed, he served as the first lieutenant-governor of Upper Canada (now Ontario) from 1792 to 1796. He encouraged immigration and agriculture and supported defense and road building.
Learn more about Simcoe, John Graves with a free trial on Britannica.com.
(born July 9, 1934, Indianapolis, Ind., U.S.) U.S. architect and designer. He studied at Harvard University and in 1962 began a long teaching career at Princeton University while designing private houses in the abstract and austere style of orthodox Modernism. In the late 1970s he rejected Modernist expression and began seeking a larger, postmodernist vocabulary. The hulking masses of the Portland Building in Portland, Ore. (1980), and the Humana Building in Louisville, Ky. (1982), display his highly personal, Cubist rendering of such Classical elements as colonnades and loggias. Though considered somewhat awkward, these and his later buildings (e.g., Indianapolis Art Center, 1996) have been acclaimed for their ironic interpretation of traditional forms. Among his later projects were the restoration of the Washington Monument (2000) and the creation of a line of household items, including kitchenware and furniture, for the discount retailer Target.
Learn more about Graves, Michael with a free trial on Britannica.com.
(born Feb. 25, 1752, Cotterstock, Northamptonshire, Eng.—died Oct. 26, 1806, Exeter, Devonshire) British soldier and colonial administrator in Canada. He served in the American Revolution as commander of the Queen's Rangers (1777–79). He was taken prisoner (1779) but later released (1781) and invalided back to England. After the Constitutional Act was passed, he served as the first lieutenant-governor of Upper Canada (now Ontario) from 1792 to 1796. He encouraged immigration and agriculture and supported defense and road building.
Learn more about Simcoe, John Graves with a free trial on Britannica.com.
(born July 9, 1934, Indianapolis, Ind., U.S.) U.S. architect and designer. He studied at Harvard University and in 1962 began a long teaching career at Princeton University while designing private houses in the abstract and austere style of orthodox Modernism. In the late 1970s he rejected Modernist expression and began seeking a larger, postmodernist vocabulary. The hulking masses of the Portland Building in Portland, Ore. (1980), and the Humana Building in Louisville, Ky. (1982), display his highly personal, Cubist rendering of such Classical elements as colonnades and loggias. Though considered somewhat awkward, these and his later buildings (e.g., Indianapolis Art Center, 1996) have been acclaimed for their ironic interpretation of traditional forms. Among his later projects were the restoration of the Washington Monument (2000) and the creation of a line of household items, including kitchenware and furniture, for the discount retailer Target.
Learn more about Graves, Michael with a free trial on Britannica.com.
In some parts of Europe the term Basedow’s disease or Graves-Basedow disease is preferred to Graves' disease.
Several earlier reports exist but were not widely circulated. For example, cases of goiter with exophthalmos were published by the Italians Giuseppe Flajina and Antonio Giuseppe Testa, in 1802 and 1810 respectively. Prior to these, Caleb Hillier Parry, a notable provincial physician in England of the late 18th-century (and a friend of Edward Miller-Gallus), described a case in 1786. This case was not published until 1825, but still ten years ahead of Graves.
However, fair credit for the first description of Graves' disease goes to the 12th-century Persian physician Sayyid Ismail Al-Jurjani, who noted the association of goiter and exophthalmos in his Thesaurus of the Shah of Khwarazm, the major medical dictionary of its time.
The two signs that are truly diagnostic of Graves' disease (i.e. not seen in other hyperthyroid conditions) are exophthalmos and non-pitting edema (pretibial myxedema). Goiter which is an enlarged thyroid gland and is of the diffuse type (i.e., spread throughout the gland). Diffuse goiter may be seen with other causes of hyperthyroidism, although Graves' disease is the most common cause of diffuse goiter. A large goiter will be visible to the naked eye, but a smaller goiter (very mild endlargement of the gland) may be detectable only by physical exam. Occasionally, goiter is not clinically detectable, but may be seen only with CT or ultrasound examination of the thyroid.
Another sign of Graves' disease is hyperthyroidism, i.e. over-production of the thyroid hormones T3 and T4. Normothyroidism is also seen, and occasionally also hypothyroidism, which may assist in causing goiter (though it is not the cause of the Graves disease). Hyperthyroidism in Graves disease is confirmed as with any other cause of hyperthyroidism, by measuring elevated blood levels of free (unbound) T3 and T4.
Other useful laboratory measurements in Graves disease include thyroid-stimulating hormone (TSH, usually low in Graves' disease due to negative feedback from the elevated T3 and T4), and protein-bound iodine (elevated). Thyroid-stimulating antibodies may also be detected serologically.
Biopsy to obtain histiological testing is not normally required, but may be obtained if thyroidectomy is performed.
Differentiating two common forms of hyperthyroidism such as Graves disease and Toxic multinodular goiter is important to determine proper treatment. Measuring TSH-receptor antibodies with the h-TBII assay has been proven efficient and was the most practical approach found in one study.
The ocular manifestations that are relatively specific to Grave's disease include soft tissue inflammation, proptosis (protrusion of one or both globes of the eyes), corneal exposure, and optic nerve compression. Also seen, if the patient is hyperthyroid, (i.e., has too much thryoid hormone) are more general manifestations which are due to hyperthyroidism itself and which may be seen in any conditions which cause hyperthyroidism (such as toxic multinodular goiter or even thryoid poisoning). These more general symptoms include lid retraction, lid lag, and a delay in the downward excursion of the upper eyelid, during downward gaze.
Some of the most typical symptoms of Graves' Disease may include the following:
The disease occurs most frequently in women (7:1 compared to men). It occurs most often in middle age (most commonly in the third to fifth decades of life), but is not uncommon in adolescents, during pregnancy, at the time of menopausal, and in people over age 50. There is a marked family preponderance, which has led to speculation that there may be a genetic component. To date, no clear genetic defect has been found that would point at a monogenic cause.
The infiltrative exophthalmos that is frequently encountered has been explained by postulating that the thyroid gland and the extraocular muscles share a common antigen which is recognized by the antibodies. Antibodies binding to the extraocular muscles would cause swelling behind the eyeball.
The "orange peel" skin has been explained by the infiltration of antibodies under the skin, causing an inflammatory reaction and subsequent fibrous plaques.
There are 3 types of autoantibodies to the TSH receptor currently recognized:
Since Graves' disease is an autoimmune disease which appears suddenly, often quite late in life, it is thought that a viral or bacterial infection may trigger antibodies which cross-react with the human TSH receptor (a phenomenon known as antigenic mimicry, also seen in some cases of type I diabetes).
One possible culprit is the bacterium Yersinia enterocolitica (a cousin of Yersinia pestis, the agent of bubonic plague). However, although there is indirect evidence for the structural similarity between the bacteria and the human thyrotropin receptor, direct causative evidence is limited. Yersinia seems not to be a major cause of this disease, although it may contribute to the development of thyroid autoimmunity arising for other reasons in genetically susceptible individuals. It has also been suggested that Y. enterocolitica infection is not the cause of auto-immune thyroid disease, but rather is only an associated condition; with both having a shared inherited susceptibility. More recently the role for Y. enterocolitica has been disputed.
The ocular manifestations of Graves' disease are more common in smokers and tend to worsen (or develop for the first time) following radioiodine treatment of the thyroid condition. Thus, they are not caused by hyperthyroidism per se. This common misperception may result from the fact that hyperthyroidism from other causes may cause eyelid retraction or eyelid lag (so-called hyperthyroid stare), which can be confused with the general appearance of proptosis or exophthalmos, despite the fact that the globes do not actually protrude in other causes of hyperthyroidism. Also, both conditions (globe protrusion and hyperthyroid lid retraction) may exist at the same time in the hyperthyroid patient with Graves' disease.
Treatment with antithyroid medications must be given for six months to two years, in order to be effective. Even then, upon cessation of the drugs, the hyperthyroid state may recur. Side effects of the antithyroid medications include a potentially fatal reduction in the level of white blood cells. The development and widespread adoption of radioiodine treatment has led to a progressive reduction in the use of surgical thyroidectomy for this problem. In general, RAI therapy is effective, less expensive, and avoids the small but definite risks of surgery.,
Therapy with radioiodine is the most common treatment in the United States, whilst antithyroid drugs and/or thyroidectomy is used more often in Europe, Japan, and most of the rest of the world.
A randomized control trial testing single dose treatment for Graves found methimazole achieved euthyroid state more effectively after 12 weeks that did propylthyouracil (77.1% on methimazole 15 mg vs 19.4% in the propylthiouracil 150 mg groups).
A study has shown no difference in outcome for adding thyroxine to antithyroid medication and continuing thyroxine versus placebo after antithyroid medication withdrawal. However two markers were found that can help predict the risk of recurrence. These two markers are a positive Thyroid Stimulating Hormone receptor antibody (TSHR-Ab) and smoking. A positive TSHR-Ab at the end of antithyroid drug treatment increases the risk of recurrence to 90% (sensitivity 39%, specificity 98%), a negative TSHR-Ab at the end of antithyroid drug treatment is associated with a 78% chance of remaining in remission. Smoking was shown to have an impact independent to a positive TSHR-Ab.
Contraindications to RAI are pregnancy (absolute), ophthalmopathy (relative; it can aggravate thyroid eye disease), solitary nodules.
Disadvantages of this treatment are a high incidence of hypothyroidism (up to 80%) requiring eventual thyroid hormone supplementation in the form of a daily pill. The radio-iodine treatment acts slowly (over months to years) to destroy the thyroid gland, and Graves disease-associated hyperthyroidism is not cured in all persons by radioiodine, but has a relapse rate that depends on the dose of radioiodine which is administered.
Both bilateral subtotal thyroidectomy and the Hartley-Dunhill procedure (hemithyroidectomy on 1 side and partial lobectomy on other side) are possible.
Advantages are: immediate cure and potential removal of carcinoma. Its risks are injury of the recurrent laryngeal nerve, hypoparathyroidism (due to removal of the parathyroid glands), hematoma (which can be life-threatening if it compresses the trachea) and scarring.
